Clinical trials
Breast Neoplasms trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
556 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 9 |
| 2007 | 16 |
| 2008 | 14 |
| 2009 | 23 |
| 2010 | 22 |
| 2011 | 18 |
| 2012 | 22 |
| 2013 | 23 |
| 2014 | 32 |
| 2015 | 27 |
| 2016 | 17 |
| 2017 | 31 |
| 2018 | 32 |
| 2019 | 34 |
| 2020 | 39 |
| 2021 | 35 |
| 2022 | 34 |
| 2023 | 31 |
| 2024 | 29 |
| 2025 | 35 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 244 |
| Recruiting | 89 |
| Unknown status | 85 |
| Active, not recruiting | 81 |
| Terminated | 40 |
| Not yet recruiting | 7 |
| Enrolling by invitation | 5 |
| Approved for marketing | 2 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 50 |
| AstraZeneca | 39 |
| Samsung Medical Center | 38 |
| Seoul National University Hospital | 38 |
| Novartis Pharmaceuticals | 32 |
| Yonsei University | 25 |
| National Cancer Center, Korea | 24 |
| Eli Lilly and Company | 20 |
| Pfizer | 20 |
| Asan Medical Center | 16 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 556 |
| Neoplasm Metastasis | 49 |
| Neoplasms | 36 |
| Stomach Neoplasms | 31 |
| Carcinoma, Non-Small-Cell Lung | 28 |
| Ovarian Neoplasms | 27 |
| Colorectal Neoplasms | 26 |
| Triple Negative Breast Neoplasms | 25 |
| Endometrial Neoplasms | 15 |
| Head and Neck Neoplasms | 15 |
Trials
Showing 51 to 75 of 556. Each trial links to its page on Pharma Observatory.
456 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.